We are live on ! Find out more
CCM

Catapult Capital Management Portfolio holdings

AUM $265M
1-Year Est. Return 21.83%
This Fund
S&P 500
This Quarter Est. Return
-6.98%
1 Year Est. Return
+21.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$265M
AUM Growth
-$431M
Cap. Flow
-$403M
Cap. Flow %
-152.44%
Top 10 Hldgs %
27.43%
Holding
286
New
68
Increased
19
Reduced
60
Closed
135

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$9.98M
2
NUVA
NuVasive, Inc.
NUVA
+$4.39M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.85M
4
BSX icon
Boston Scientific
BSX
+$3.16M
5
PFE icon
Pfizer
PFE
+$3.04M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$16M
2
ABBV icon
AbbVie
ABBV
+$15.9M
3
ZTS icon
Zoetis
ZTS
+$13.5M
4
PEP icon
PepsiCo
PEP
+$12.8M
5
MCK icon
McKesson
MCK
+$12.4M

Sector Composition

Rank Sector Weight
1 Healthcare 41.36%
2 Consumer Discretionary 7.36%
3 Industrials 6.49%
4 Technology 4.09%
5 Financials 3.01%

No holdings matched the selected filter criteria.

8 9 10 11 12

Similar funds

LOCB
Lombard Odier & Cie (Bahamas) Nassau, Bahamas $263M AUM 3.37% 1-Year Est. Return
AF
Adirondack Funds Guilderland, New York $261M AUM
TCOTO
Trust Company of the Ozarks Springfield, Missouri $290M AUM 12.7% 1-Year Est. Return
DCM
Dinsmore Capital Management Morristown, New Jersey $230M AUM 0.29% 1-Year Est. Return
SCA
Samson Capital Advisors New York $228M AUM 0.84% 1-Year Est. Return
LPVHS
Lexington Partners VI Holdings Sub New York $227M AUM 24.75% 1-Year Est. Return
ATC
Argent Trust Company Ruston, Louisiana $225M AUM 5.44% 1-Year Est. Return
TFF
Timothy F. Fidgeon $203M AUM 2.36% 1-Year Est. Return

Catapult Capital Management's Q3 2015 Portfolio in Review

As of Q3 2015, Catapult Capital Management held 286 positions worth $265M, down 62% from $696M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Catapult Capital Management withdrew a net $403M in Q3 2015, closing 135 positions and reducing 60 holdings. Its most notable exit was PepsiCo, an estimated $12.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 43% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Catapult Capital Management opened a new position in Vertex Pharmaceuticals worth $3.12M.

  • Catapult Capital Management's largest Q3 2015 buy was Vertex Pharmaceuticals: 30,000 shares worth $3.12M.
  • Catapult Capital Management added most to Allergan plc in Q3 2015, an estimated $9.98M increase.
  • Catapult Capital Management's biggest Q3 2015 reduction was CVS Health, cutting an estimated $16M.
  • Catapult Capital Management fully exited PepsiCo in Q3 2015, selling an estimated $12.8M.
  • Catapult Capital Management's ten largest holdings make up 27% of its $265M portfolio in Q3 2015.
  • Catapult Capital Management opened 68 new positions and closed 135 in Q3 2015.
  • Catapult Capital Management's portfolio value fell 62% quarter-over-quarter to $265M.

Based on Catapult Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.